In recent trading session, 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) saw 0.33 million shares changing hands at last check today with its beta currently measuring 4.18. Company’s recent per share price level of $0.77 trading at -$0.03 or -3.72% at last check today assigns it a market valuation of $1.77M. That most recent trading price of SXTP’s stock is at a discount of -835.06% from its 52-week high price of $7.20 and is indicating a premium of 9.09% from its 52-week low price of $0.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.46 million shares which gives us an average trading volume of 1.66 million if we extend that period to 3-months.
For 60 Degrees Pharmaceuticals Inc (SXTP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.65 in the current quarter.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
Upright in the red during last session for losing -3.72%, in the last five days SXTP remained trading in the red while hitting it’s week-highest on Wednesday, 01/29/25 when the stock touched $0.77 price level, adding 35.83% to its value on the day. 60 Degrees Pharmaceuticals Inc’s shares saw a change of -40.29% in year-to-date performance and have moved -13.87% in past 5-day. 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) showed a performance of -39.35% in past 30-days. Number of shares sold short was 37296.0 shares which calculate 0.34 days to cover the short interests.
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
Statistics highlight that 60 Degrees Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -56.49% of value to its shares in past 6 months, showing an annual growth rate of 79.42% while that of industry is 17.20. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 145.49% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 234k for the same. And 1 analysts are in estimates of company making revenue of 300k in the next quarter. Company posted 125.68k and 116.46k of sales in current and next quarters respectively a year earlier.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
Insiders are in possession of 10.58% of company’s total shares while institution are holding 1.25 percent of that, with stock having share float percentage of 1.40%. Investors also watch the number of corporate investors in a company very closely, which is 1.25% institutions for 60 Degrees Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024, the former fund manager was holding 3.88 shares of worth $2926.0 or 0.17% of the total outstanding shares. The later fund manager was in possession of 2.14 shares on Oct 31, 2024, making its stake of worth around $1613.0 in the company or a holder of 0.09% of company’s stock.
